Bayu S, Alemayehu W
Department of Ophthalmology, Faculty of Medicine, Addis Ababa University, Ethiopia, East Africa.
Clin Infect Dis. 1997 Jun;24(6):1256-60. doi: 10.1086/513626.
We conducted a prospective study of 100 consecutive Ethiopian patients with herpes zoster ophthalmicus (HZO); this study revealed a high incidence of HZO among the young (mean age, 35 years). Eighty-one (95%) of 85 patients who underwent serological testing were seropositive for antibodies to human immunodeficiency virus (HIV). Unlike previous investigators, we found a marked increase in the incidence and severity of eyelid (25%) and ocular (78%) complications as well as postherpetic neuralgia (55%). Visual loss occurred in 56% of the cases. Lack of medication, delay in presentation, severity of HIV-related HZO, and application of herbal medications adversely affected the outcomes for these patients. We conclude that all patients with HZO, especially those younger than 45 years of age, should be screened for HIV infection. Because HZO is a vision-threatening problem, all health care workers should become aware of its management.
我们对100例连续的患有眼部带状疱疹(HZO)的埃塞俄比亚患者进行了一项前瞻性研究;该研究显示HZO在年轻人(平均年龄35岁)中的发病率很高。在接受血清学检测的85例患者中,有81例(95%)的人类免疫缺陷病毒(HIV)抗体呈血清阳性。与之前的研究者不同,我们发现眼睑并发症(25%)、眼部并发症(78%)以及疱疹后神经痛(55%)的发病率和严重程度显著增加。56%的病例出现了视力丧失。药物缺乏、就诊延迟、与HIV相关的HZO的严重程度以及草药的使用对这些患者的预后产生了不利影响。我们得出结论,所有HZO患者,尤其是45岁以下的患者,都应接受HIV感染筛查。由于HZO是一个威胁视力的问题,所有医护人员都应了解其治疗方法。